Please refer to JobSuchmaschine in your application
Switzerland, Basel-Town, Basel
United States, California, South San Francisco
United Kingdom, England, Welwyn Garden City, Hertfordshire
In PDO, the iPODD pediatric team is responsible for the clinical development of the entire Roche ‘late stage’ portfolio for children with cancer.
The iPODD team has implemented a MATRIX trial for phase 1/2 trials with multiple molecules. Currently, we are actively recruiting patients in the Atezolizumab and in the Cobimetinib trial.
We are expecting to open 2-4 more molecules in the iMATRIX in the near future. For other molecules phase 1-2-3 trials have been performed, such as Avastin, Rituximab and Zelboraf. We are actively filing these data in the EU and US for Avastin and Rituxan